Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block

Recruiting now

Conditions studied: Heart Block Complete, Heart Block Second Degree

In brief

Few studies are specifically designed to address health concerns that are already relevant during pregnancy. The consequence is a lack of evidence on best clinical practice. This includes mothers and their babies when pregnancy is complicated by an abnormally slow heart rate due to maternal antibody-mediated heart disease in the unborn baby (fetus). Since the late seventies, it has been possible to detect and monitor fetal disease by ultrasound images and to treat selected conditions with pharmaceuticals administered via the mother. To this day, physicians need to make decisions about the management of such pregnancies without evidence from prospective clinical trials on drug efficacy and safety. The SLOW HEART REGISTRY is a multi-centered prospective observational study that will address the knowledge gap to guide future management of high-degree immune-mediated heart block to the best of care. The study seeks to establish an international database of the management and outcome of affected fetuses, to be used to publish information on the results of currently available prenatal care and to evaluate the need for additional research.

Key facts

Study ID

NCT04559425

Run by

The Hospital for Sick Children

People needed

350

Starts

2020-01-01

Expected to finish

2029-12-31

Last updated by the study team

2024-05-22

Who can join

Age: 16 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Written informed maternal consent to participate in the Slow Heart Registry
• High-degree (2nd; 2:1; 2nd-3rd or 3rd degree) AVB diagnosed ≤ 32+0 weeks with or without hydrops
• Enrollment within maximally 8 days of high-degree AVB diagnosis
• Positive or pending anti-Ro/La antibody test results at the time of enrollment

You may not qualify if…

• AVB associated with major CHD (e.g. left atrial isomerism, cc-TGA)
• AVB with known negative anti-Ro and/or La antibody test result at enrollment
• 1st degree AVB
• Sinus bradycardia with normal 1:1 AV conduction
• Blocked atrial bigeminy (irregular atrial rate with failure of AV conduction of the premature atrial beat)
• Primary delivery for postnatal treatment
• Maternal-fetal conditions (other than cardiac NL) associated with high odds of premature delivery or death (e.g. renal failure, significant infectious diseases, major extracardiac anomalies, PROM, etc.)
• Preexisting maternal mental disorder (e.g. bipolar, mania, severe depression, substance abuse)
• Poorly controlled insulin-dependent diabetes (HbA1c >7%) at CAVB diagnosis
• Oligohydramnios (deepest/maximal vertical pocket <2 cm)
• Severe IUGR (estimated fetal weight <3rd percentile)

Where it is running

• Phoenix Children's Hospital — Phoenix, Arizona, United States (enrolling)
• University of California San Francisco — San Francisco, California, United States (enrolling)
• Children's Hospital Colorado — Denver, Colorado, United States (enrolling)
• Children's National Medical Center — Washington D.C., District of Columbia, United States (enrolling)
• Johns Hopkins All Children's Hospital — St. Petersburg, Florida, United States (enrolling)
• Children's Mercy Kansas City — Kansas City, Kansas, United States (enrolling)
• Boston Children's Hospital — Boston, Massachusetts, United States (enrolling)
• The Children's Heart Clinic/Children's Minnesota — Minneapolis, Minnesota, United States (enrolling)
• Columbia University (New York) — New York, New York, United States (enrolling)
• Texas Children's Hospital — Houston, Texas, United States (enrolling)
• Seattle Children's Hospital — Seattle, Washington, United States (enrolling)
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States (enrolling)
• National Heart Hospital — Sofia, Bulgaria (enrolling)
• IWK Nova Scotia Health — Halifax, Nova Scotia, Canada (enrolling)
• The Hospital for Sick Children — Toronto, Canada (enrolling)
• Hospital District of Helsinki and Uusimaa — Helsinki, Finland (enrolling)
• Grenoble University Hospital — Grenoble, France (enrolling)
• University of Bonn — Bonn, Germany (enrolling)
• Hong Kong Children's Hospital — Ngau Tau Kok, Hong Kong (enrolling)
• Kanagawa Children's Medical Center — Kanagawa, Japan (enrolling)
• Shizuoka Children's Hospital — Shizuoka, Japan (enrolling)
• Leiden University Medical Center - LUMC — Leiden, Netherlands (enrolling)
• Centre of Postgraduate Medical Education Poland — Warsaw, Poland (enrolling)
• Queen Silvia Children's Hospital — Gothenburg, Sweden (enrolling)
• Skane University Hospital in Lund — Lund, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.